Figure 7

Cerebrospinal fluid levels of amyloid-beta oligomers, Aβ42, t-tau and p-tau in Cohort 3. Mild cognitive impairment subjects (MCI, n = 23) and age-matched controls (CON, n = 17) were analyzed. Significant differences are indicated. Labeling as in Figure 6. oAβ, amyloid-beta oligomers. Erenna platform (Singulex, Alameda, CA, USA).